About ingenious targeting laboratory
ingenious targeting laboratory is a Healthcare company based in Ronkonkoma (United States) founded in 1998 by Paul Sheiffele. Custom gene targeting and mouse model services are offered. The company has 22 employees. ingenious targeting laboratory offers products and services including Custom Mouse Models, Knockout Mouse Models, Catalog Models, and Preclinical Solutions. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its competitors include Poseida Therapeutics, Senti Biosciences and Biocytogen; 3 of its 3 listed competitors have raised funding.
Company details
Ingenious Targeting Laboratory was founded in 1998 and is based in Ronkonkoma, United States. Operations focus on the biotechnology sector, where custom gene targeting services are provided, including mouse knockouts, knock-ins, mutagenesis, and ES cell screening. Specialized mouse models such as Humanized Mice, Knockout Mice, and CRISPR Transgenic Mice are also developed and supplied to support research needs.
- Headquarters Ronkonkoma, United States
- Employees 22
- Founders Paul Sheiffele
- SectorsHealthcare
- Website genetargeting.com
- Social LinkedIn X
- Latest Funding Round$589.91K (USD), Grant
Jan 2021
- Investors
- Employee Count22
Products & Services of ingenious targeting laboratory
ingenious targeting laboratory offers a comprehensive portfolio of products and services, including Custom Mouse Models, Knockout Mouse Models, Catalog Models, and Preclinical Solutions.
Tailored mouse models for specific research needs in genetics.
Mice with targeted gene knockouts for experimental studies.
Ready-to-ship genetically modified mice for various applications.
Services for drug efficacy and safety testing in models.
Funding Insights of ingenious targeting laboratory
- Total Rounds 3
- Last Round Grant — $589,914
- First Round $3.57M
(Mar 2018)
- Investors Count 1
All 3 funding rounds of ingenious targeting laboratory with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in ingenious targeting laboratory
ingenious targeting laboratory has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for ingenious targeting laboratory
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ingenious targeting laboratory
5 people are tracked at ingenious targeting laboratory (3 in leadership, 2 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Paul Sheiffele | Founder & President | Leadership |
Wei Weng | CSO and CEO | Leadership |
Milen Kirilov, PhD | Director of Molecular Biology and Genetics | Leadership |
Mikaela Vallas | Scientific Project Manager/ Genotyping& Screening Supervisor | Team |
Kelly Tseng | Project Manager | Team |
Complete people profiles for ingenious targeting laboratory
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ingenious targeting laboratory
3 dated milestones of ingenious targeting laboratory across 23 years, from founding to its latest funding, stage changes and deals.
- Founded ingenious targeting laboratory is founded.
- Funding First funding round of $3.6M.
- Funding Latest funding round, Grant, of $590K.
Competitors of ingenious targeting laboratory
ingenious targeting laboratory has 3 listed competitors in our database, 3 of them funded. They include Poseida Therapeutics, Senti Biosciences and Biocytogen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| sentibio.com | 2016 | San Francisco, United States | $158M | Cell-based therapies for cancer treatment are developed. | ||
| biocytogen.com | 2008 | Wakefield, United States | $301.11M | 85 | Integrated solutions for next-generation antibody drug development are provided. |
Detailed competitors of ingenious targeting laboratory
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ingenious targeting laboratory
The website of ingenious targeting laboratory (genetargeting.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 6.2% vs previous month
Websites whose visitors overlap most with ingenious targeting laboratory. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genoway.com | 100% | 10K | #2,373,054 | View details | |
| taconic.com | 100% | 49.8K | #707,498 | View details | |
knockoutmouse.org | knockoutmouse.org | 98% | – | ||
| deltagen.com | 93% | View details | |||
| sageresearchmodels.com | 91% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for ingenious targeting laboratory
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as ingenious targeting laboratory (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ingenious Targeting Laboratory
Complete news archive for ingenious targeting laboratory
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ingenious targeting laboratory
ingenious targeting laboratory was founded in 1998 and raised its 1st funding round 20 years after it was founded.
ingenious targeting laboratory is headquartered in Ronkonkoma, United States. It is registered at Ronkonkoma, New York, United States.
ingenious targeting laboratory has 22 employees.
Ingenious Targeting Laboratory was founded in 1998 and is based in Ronkonkoma, United States. Operations focus on the biotechnology sector, where custom gene targeting services are provided, including mouse knockouts, knock-ins, mutagenesis, and ES cell screening. Specialized mouse models such as Humanized Mice, Knockout Mice, and CRISPR Transgenic Mice are also developed and supplied to support research needs.
ingenious targeting laboratory's top competitors include Biocytogen, Senti Biosciences and Poseida Therapeutics.
ingenious targeting laboratory offers Custom Mouse Models, Knockout Mouse Models, Catalog Models, and Preclinical Solutions.
ingenious targeting laboratory has 1 investor. Key investors include HHS.